A new clinical development program, PALM, is testing TPIP in 3 active clinical trials in patients with PAH and other ...
A new clinical development program, PALM, is testing TPIP in 4 clinical trials in patients with IPF and other conditions.
Clinicians initially suspected SM in a man with a blast-phase PDGFRA neoplasm with basophilia, spindle-shaped mast cells, and ...
Intensive chemotherapy and allogeneic hematopoietic cell transplantation put t(8;21) acute myeloid leukemia (AML) into ...
Zanubrutinib was associated with significantly better overall survival than ibrutinib or acalabrutinib among veterans with ...
Researchers proposed a workflow for distinguishing PMDs from MoCD and ISOD in neonates with seizures, hypotonia, and encephalopathy.
Moderate-to-severe bone marrow fibrosis was associated with inferior overall survival, particularly in patients with ...
Combined immunoadsorption, high-dose IVIG, and rituximab may help manage pregnancies at high risk for severe HDFN, per a ...
A planned phase 2 clinical trial will evaluate tegacorat, an experimental SEGRAM, in boys with Duchenne muscular dystrophy (DMD).
Patients with NMOSD show a distinct prodromal signature up to 5 years before diagnosis, according to an analysis of UCSF health records.
Serial ODDS scoring provides superior, dynamic risk discrimination for mortality or lung transplantation in patients with IPF ...
Alyssa Gloor receives infusion therapy, without a port, to treat her AATD. She shares how diet can help or harm her infusion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results